EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Panax ginseng Across the Cardiovascular Continuum: Molecular Targets, Mechanistic Convergence, and Translational Challenges

Min Qiao, Chang Sun, Yangyang Qin, Di Wu, Ming Tian, Mingxia Wu, Hang Su, Xiangyan Li

Biomolecules · 01.11.2026 · 16 (11) · 1584

DOI: 10.3390/biom16111584 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biomolecules, online erschienen am 01.11.2026. Verfasst von Min Qiao und 7 weiteren Autor:innen. Die Arbeit nennt 220 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Administration of Traditional Chinese Medicine, Science and Technology Development Plan Project of Jilin Province.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiovascular diseases develop through an interconnected continuum that extends from cardiometabolic risk factors and vascular dysfunction to myocardial ischemic injury, pathological remodeling, and heart failure. Panax ginseng and its bioactive constituents have shown cardiovascular protective effects in various experimental models. However, the molecular mechanisms shared across different stages of the cardiovascular continuum remain insufficiently integrated. This review critically synthesizes current evidence on Panax ginseng, ginseng-derived constituents, and ginseng-containing preparations across major stages of cardiovascular disease. Particular emphasis is placed on convergent molecular networks involving metabolic and mitochondrial homeostasis, oxidative stress and inflammation, autophagy and mitophagy, regulated cell death, calcium handling, vascular and fibrotic remodeling, and gut microbiota–host interactions. Several target-oriented mechanisms, including peroxisome proliferator activated receptor (PPAR) γ, ryanodine receptor 2, histone acetyltransferase P300/dihydrolipoamide dehydrogenase/pyruvate dehydrogenase, Fas-associated death domain/PPARα, and sarcoplasmic/endoplasmic reticulum Ca2+-ATPase 2A-associated regulation, are highlighted and distinguished from pathway-level or phenotypic evidence. Despite extensive preclinical data, direct target engagement, causal validation, pharmacokinetic characterization, preparation standardization, and clinical evidence remain limited. Integrating target-level validation with standardized ginseng interventions and clinically relevant models may provide a stronger molecular basis for evaluating the cardiovascular potential of ginseng.

Förderung

  • National Administration of Traditional Chinese Medicine
  • Science and Technology Development Plan Project of Jilin Province

Zitieren

APA

Qiao, M., Sun, C., Qin, Y., Wu, D., Tian, M., Wu, M., Su, H., & Li, X. (2026). Panax ginseng Across the Cardiovascular Continuum: Molecular Targets, Mechanistic Convergence, and Translational Challenges. Biomolecules, 16(11), 1584. https://doi.org/10.3390/biom16111584

Vancouver

Qiao M, Sun C, Qin Y, Wu D, Tian M, Wu M, et al. Panax ginseng Across the Cardiovascular Continuum: Molecular Targets, Mechanistic Convergence, and Translational Challenges. Biomolecules. 2026;16(11):1584. doi:10.3390/biom16111584

BibTeX
@article{Qiao2026,
  author = {Qiao, Min and Sun, Chang and Qin, Yangyang and Wu, Di and Tian, Ming and Wu, Mingxia and Su, Hang and Li, Xiangyan},
  title = {Panax ginseng Across the Cardiovascular Continuum: Molecular Targets, Mechanistic Convergence, and Translational Challenges},
  journal = {Biomolecules},
  year = {2026},
  volume = {16},
  number = {11},
  pages = {1584},
  doi = {10.3390/biom16111584}
}
Kostenlos starten →